Company intelligence / Profile preview

Shanghai Telebio Biomedical

Ownership: Private
Development stage: Other

Overview

Shanghai Telebio Biomedical is an active Chinese biotechnology company specializing in the development, manufacturing, and supply of lentiviral vectors used in gene therapy, cell therapy R&D, and related biomedical applications. Their products are widely used by academic labs and biopharma companies to enable advanced genetic engineering projects including CAR-T therapies. No direct clinical results are attributed to the company itself since it acts as an enabler/CDMO.

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Lentiviral vectorGene therapy vectorCell therapy support products
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Shanghai Telebio Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Telebio Biomedical.

Explore the full profile